Low density lipoprotein particle size and coronary artery disease. 1992

H Campos, and J J Genest, and E Blijlevens, and J R McNamara, and J L Jenner, and J M Ordovas, and P W Wilson, and E J Schaefer
Lipid Metabolism Laboratory, US Department of Agriculture Human Nutrition Research Center on Aging at Tufts University, Mass. 02111.

Decreased plasma low density lipoprotein (LDL) particle size has been associated with premature coronary artery disease (CAD). We examined LDL particle size by 2-16% gradient gel electrophoresis in 275 men with CAD (greater than 75% cross-sectional-area stenosis) and 822 controls. Seven major LDL size bands (with LDL-1 [d = 1.025-1.033 g/ml] being the largest and LDL-7 [d = 1.050-1.063 g/ml, the smallest]) were identified. Because most subjects had two or more adjacent LDL bands, an LDL score was calculated for each subject, with the relative area in each band taken into consideration. Four major LDL particle size groups were classified in the present studies: large LDL, intermediate LDL, small LDL, and very small LDL. The use of beta-blockers was significantly associated with smaller LDL particles. After adjusting for use of this medication, small LDL particles were still more prevalent in CAD patients (39%) compared with controls (27%). The prevalence of large LDL particles was lower in CAD patients (3%) than in controls (24%). Intermediate LDL particles were the most prevalent in both groups, 49% in CAD patients and 46% in controls. The difference in LDL particle size between CAD patients and controls was not independent but was highly associated (p less than 0.0001) with elevated triglyceride levels and decreased high density lipoprotein (HDL) cholesterol levels. Significantly higher LDL cholesterol levels were found in subjects with intermediate and small LDL particles than in those with large or very small LDL particles.(ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D008055 Lipids A generic term for fats and lipoids, the alcohol-ether-soluble constituents of protoplasm, which are insoluble in water. They comprise the fats, fatty oils, essential oils, waxes, phospholipids, glycolipids, sulfolipids, aminolipids, chromolipids (lipochromes), and fatty acids. (Grant & Hackh's Chemical Dictionary, 5th ed) Lipid
D008077 Lipoproteins, LDL A class of lipoproteins of small size (18-25 nm) and light (1.019-1.063 g/ml) particles with a core composed mainly of CHOLESTEROL ESTERS and smaller amounts of TRIGLYCERIDES. The surface monolayer consists mostly of PHOSPHOLIPIDS, a single copy of APOLIPOPROTEIN B-100, and free cholesterol molecules. The main LDL function is to transport cholesterol and cholesterol esters to extrahepatic tissues. Low-Density Lipoprotein,Low-Density Lipoproteins,beta-Lipoprotein,beta-Lipoproteins,LDL(1),LDL(2),LDL-1,LDL-2,LDL1,LDL2,Low-Density Lipoprotein 1,Low-Density Lipoprotein 2,LDL Lipoproteins,Lipoprotein, Low-Density,Lipoproteins, Low-Density,Low Density Lipoprotein,Low Density Lipoprotein 1,Low Density Lipoprotein 2,Low Density Lipoproteins,beta Lipoprotein,beta Lipoproteins
D008078 Cholesterol, LDL Cholesterol which is contained in or bound to low density lipoproteins (LDL), including CHOLESTEROL ESTERS and free cholesterol. LDL Cholesterol,Cholesteryl Linoleate, LDL,LDL Cholesteryl Linoleate,Low Density Lipoprotein Cholesterol,beta-Lipoprotein Cholesterol,Cholesterol, beta-Lipoprotein,beta Lipoprotein Cholesterol
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010316 Particle Size Relating to the size of solids. Particle Sizes,Size, Particle,Sizes, Particle
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

H Campos, and J J Genest, and E Blijlevens, and J R McNamara, and J L Jenner, and J M Ordovas, and P W Wilson, and E J Schaefer
September 1990, The American journal of cardiology,
H Campos, and J J Genest, and E Blijlevens, and J R McNamara, and J L Jenner, and J M Ordovas, and P W Wilson, and E J Schaefer
April 1999, Metabolism: clinical and experimental,
H Campos, and J J Genest, and E Blijlevens, and J R McNamara, and J L Jenner, and J M Ordovas, and P W Wilson, and E J Schaefer
September 2004, Diabetes research and clinical practice,
H Campos, and J J Genest, and E Blijlevens, and J R McNamara, and J L Jenner, and J M Ordovas, and P W Wilson, and E J Schaefer
November 2004, Current atherosclerosis reports,
H Campos, and J J Genest, and E Blijlevens, and J R McNamara, and J L Jenner, and J M Ordovas, and P W Wilson, and E J Schaefer
December 2010, Journal of atherosclerosis and thrombosis,
H Campos, and J J Genest, and E Blijlevens, and J R McNamara, and J L Jenner, and J M Ordovas, and P W Wilson, and E J Schaefer
March 2012, The Journal of pediatrics,
H Campos, and J J Genest, and E Blijlevens, and J R McNamara, and J L Jenner, and J M Ordovas, and P W Wilson, and E J Schaefer
August 2012, Korean circulation journal,
H Campos, and J J Genest, and E Blijlevens, and J R McNamara, and J L Jenner, and J M Ordovas, and P W Wilson, and E J Schaefer
January 2011, Cardiology,
H Campos, and J J Genest, and E Blijlevens, and J R McNamara, and J L Jenner, and J M Ordovas, and P W Wilson, and E J Schaefer
August 1993, Clinical chemistry,
H Campos, and J J Genest, and E Blijlevens, and J R McNamara, and J L Jenner, and J M Ordovas, and P W Wilson, and E J Schaefer
January 2007, Medicinski arhiv,
Copied contents to your clipboard!